Skip to main content
Log in

Phase I clinical trial with a combination of methotrexate and mitomycin C

  • Letter to the Editors
  • Methotrexate and Mitomycin C
  • Published:
Cancer Chemotherapy and Pharmacology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Crooke ST, Bradner WT (1976) Mitomycin C: A review. Cancer Treat Rev 3: 121

    Google Scholar 

  2. Kaplan BH, Vogl SE, Lerner H (1980) Head and neck cancer (HNCa) chemotherapy with diamminedichloroplatinum (D), bleomycin (B), methotrexate (M), and mitomycin (Mito)-“Mito-MBD”. Proc Am Ass Cancer Res and ASCO 21:478

    Google Scholar 

  3. Mabel JA (1980) Combination chemotherapy and scheduling of methotrexate and mitomycin C against murine tumors. Proc Am Assoc Res and ASCO 21:291

    Google Scholar 

  4. Muggia FM, Rozencweig M, Louie AC (1980) Role of chemotherapy in head and neck cancer: Systemic use of single agents and combination in advanced disease. Head & Neck Surg 2:196

    Google Scholar 

  5. Wheeler RH, Earhart RH, Bull FE (1979) Bleomycin (B), Oncovin (O), Mitomycin-C (Mito-C), Methotrexate (MTX) for squamous cell carcinoma. Proc Am Assoc Cancer Res and ASCO 20:348

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

This work was supported by grant no3.4535.79 of the “Fonds de la Recherche Scientifique Médicale” (FRSM-Belgium)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Body, JJ., Rozencweig, M. & Kenis, Y. Phase I clinical trial with a combination of methotrexate and mitomycin C. Cancer Chemother. Pharmacol. 6, 197–198 (1981). https://doi.org/10.1007/BF00262343

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00262343

Keywords

Navigation